{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:40:52Z","timestamp":1794570052969,"version":"4.9.1"},"reference-count":34,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Chemo Research S.L."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Gynecological Endocrinology"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/09513590.2025.2458708","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T11:05:45Z","timestamp":1738667145000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Effect over coagulation and fibrinolysis parameters of a prolonged release 24\u2009+\u20094 daily use regime contraceptive formulation containing 2\u2009mg dienogest\/0.02\u2009mg ethinylestradiol"],"prefix":"10.1080","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-2847","authenticated-orcid":false,"given":"Pedro-Antonio","family":"Regidor","sequence":"first","affiliation":[{"name":"Exeltis HealthCare, Germany","place":["Ismaning, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicyoy","family":"Angulo","sequence":"additional","affiliation":[{"name":"Exeltis HealthCare Madrid","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Colli","sequence":"additional","affiliation":[{"name":"Exeltis HealthCare Madrid","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)91061-3"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6519.526"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(95)91929-5"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115799"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/21.1.48"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(94)90286-0"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91927-9"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(96)07496-x"},{"key":"e_1_3_5_10_1","unstructured":"European Medicines Agency. Benefits of combined hormonal contraceptives (CHCs) continue to outweigh risks \u2013 CHMP endorses PRAC recommendation. EMA\/35464\/2014. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/benefits-combined-hormonal-contraceptives-chcs-continue-outweigh-risks_en.pdf."},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5298"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/13625180600772741"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2010.01.045"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04720.x"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh612"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19833"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2024.2398433"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2003.09.016"},{"key":"e_1_3_5_19_1","unstructured":"PRAC referral assessment report. Procedure under Article 31 of Directive 2001\/83\/EC resulting from pharmacovigilance data. Combined hormonal contraceptives containing medicinal products INN: chlormadinone desogestrel dienogest drospirenone etonogestrel gestodene nomegestrol norelgestromin or norgestimate. Procedure number: EMEA\/H\/A-31\/1356; 2013."},{"key":"e_1_3_5_20_1","volume-title":"WHO medical eligibility criteria for contraceptive use","year":"2015","unstructured":"WHO medical eligibility criteria for contraceptive use. 5th ed.; 2015. World Health Organisation","edition":"5"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1715793"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111840"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6423"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(96)00994-2"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-5122(96)82003-2"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S22645"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S39371"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/den1049"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181636fe9"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/13625187.2011.604450"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-05-0327"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613747"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1184-3"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2020.08.015"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0010-7824(97)00094-2"}],"container-title":["Gynecological Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09513590.2025.2458708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T19:43:10Z","timestamp":1768938190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09513590.2025.2458708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/09513590.2025.2458708"],"URL":"https:\/\/doi.org\/10.1080\/09513590.2025.2458708","relation":{},"ISSN":["0951-3590","1473-0766"],"issn-type":[{"value":"0951-3590","type":"print"},{"value":"1473-0766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=igye20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=igye20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2458708"}}